Skip to main content
. 2015 May 6;10(5):e0124835. doi: 10.1371/journal.pone.0124835

Fig 12. Activity of the VEGF promoter and the Claudin-2 promoter in Caco-2 cells treated with IAP.

Fig 12

A: The DNA binding domains of SP-1 and Cdx-1 respectively. B: The ChIP assay was performed to examine the DNA-binding activity of SP1 to the VEGF promoter and of Cdx-2 to the Claudin-2 promoter in Caco-2 cells receiving varying IAP treatments. C: The quantification of SP1 and VEGF promoter PCR data; the data were analyzed using the Image J software.